โบท็อกซ์

What botox is (and is not)

Botulinum toxin type A is a neurotoxic protein that, in the controlled microdoses used clinically, blocks the release of acetylcholine at neuromuscular junctions. Injected in measured units into a target muscle, it temporarily prevents the muscle from contracting; the cosmetic effect is a softening of the dynamic lines created by that muscle's repeated contraction over years. The molecule and the mechanism are identical across all approved brands; what differs between products is the carrier protein, the dilution, the diffusion radius, and the onset timing.

Cosmetic indications addressed at most Gangnam clinics:

• Glabellar lines (frown, between brows) — the FDA-original indication and the highest-volume cosmetic use globally
• Forehead lines (horizontal)
• Lateral canthal lines (crow's feet)
• Masseter (jaw-slimming for muscle-driven facial width)
• Platysmal bands (neck cord softening)
• Bunny lines (nose-scrunching lines)
• Lip flip (subtle upper-lip eversion)
• Gummy smile (excessive gum show on smiling)
• Mentalis (chin dimpling / pebbled appearance)
• Trapezius (shoulder-line slimming for cosmetic neck length)

Botox is not the same as filler. Filler adds volume; botox softens muscle activity. They do opposite things and address different indications. Fine static lines (lines that exist at rest, not just with movement) generally need filler or skin treatments; dynamic lines (lines that appear with expression) need botox. Many patients use both for different concerns in the same visit.

It is also not the same as biostimulators (Sculptra, Radiesse), which trigger collagen production over months; not the same as skin boosters (Profhilo, Restylane Skinboosters), which improve skin quality through hyaluronic acid microinjection; and not the same as energy-based devices (HIFU, RF, lasers), which target deeper tissue or skin surface. Botox addresses muscle activity specifically and cleanly.

What patients actually report

Our reviews database holds limited botox-specific entries — most botox reviews aggregate under broader cosmetic-clinic experience reports rather than procedure-specific tagging. Patterns below are aggregated from international forums (RealSelf botox boards, Reddit r/30PlusSkinCare, Korean platforms), comparative pricing aggregators, and peer-reviewed satisfaction literature on cosmetic botulinum toxin.

First-time patients consistently report relief that the procedure is less dramatic than expected. Most reviewers describe natural softening rather than a frozen look at 14 days, with results that friends and colleagues notice as "looking rested" rather than as obviously done. Patients who chose conservative dosing for a first session generally describe the experience positively. Patients who arrived with fixed dose preferences from prior research and pushed for higher doses report mixed results — typically more dramatic effects at 3 weeks but increasing dissatisfaction at 6–8 weeks as the over-treated areas read as expressionless.

Masseter botox satisfaction tracks honest expectation-setting. Korean injectors typically describe masseter as a 6-month-out result that requires 2–3 sessions to fully soften the muscle bulk, not a 2-week result. Reviewers who understood this timeline at consultation describe the procedure as effective; reviewers who expected the immediate slimming effect that some advertising implies describe the first session as disappointing.

Duration variance between patients is meaningful and frequently misattributed. One patient gets 5 months from a session, another gets 3 from the same dose and brand. The causes include muscle bulk, metabolic rate, exercise frequency (heavy facial expression accelerates breakdown), and some genuine inter-patient variability. Reviewers who attribute shorter duration to "fake product" or "clinic dilution" are usually misreading individual variance.

Brand-switching is normalized in long-term users. Reviewers with several years of botox history frequently describe switching between Allergan, Galderma, and Korean domestic brands across sessions, generally without noticing meaningful differences in cosmetic outcome. Brand consistency matters more for patients tracking specific dose-response patterns than for typical episodic use.

The filtered botox reviews show what we have today.

Cautions from clinical practice

Botox in trained hands has a well-characterized complication profile — most events are technique-related rather than product-related, and almost all resolve as the toxin effect wears off (3–5 months).

Eyelid ptosis (drooping upper eyelid). Diffusion of toxin into the levator palpebrae superioris muscle (the muscle that lifts the upper eyelid) produces visible eyelid droop. Reported rates are 1–3% in primary cosmetic injection in trained hands and reflect injection-site error (too low or too lateral on the forehead, with diffusion into the orbit). Apraclonidine eye drops, prescribed and supervised by a physician, can lift the lid temporarily; the effect resolves fully as the toxin wears off (typically 3–6 weeks).

Brow ptosis (heavy brow appearance). Over-treatment of the frontalis (forehead lifting muscle) without paired treatment of the depressor muscles can produce a heavy, low-set brow appearance. The effect resolves over weeks as the toxin wears off. Conservative forehead dosing with paired glabellar treatment minimizes the risk.

Asymmetric expression. Differential dose effect between the two sides — either from injection-site asymmetry or differential individual response — produces uneven brow position, smile asymmetry, or other expression imbalances. Most cases are minor and resolve as the toxin wears off; clinically meaningful asymmetry can be corrected by touch-up injection at week 2 to balance the sides.

Masseter-specific complications. Aggressive masseter dosing (above ~50 units per side in published series) increases risk of paradoxical bulging during chewing, temporary chewing weakness, and (rarely) salivary gland changes. Korean injectors typically use lower per-site doses spread across the masseter belly rather than concentrated injection.

Bruising at injection sites. Pinpoint bruising at injection sites occurs in 10–20% of patients and resolves over 3–7 days. Patients on blood thinners or supplements that affect coagulation (fish oil, vitamin E, NSAIDs) bruise more readily. Avoiding these for 5–7 days pre-injection reduces the rate.

Allergic reaction. True allergic reactions to botulinum toxin are rare (under 0.1% across published series), but reported. The carrier protein and other formulation components can produce reactions in sensitive patients. Patients with prior reactions to botulinum products should disclose this at consultation.

Antibody-mediated resistance (tachyphylaxis). Repeated exposure can produce neutralizing antibodies that reduce response over time. Reported rates are 1–3% in long-term cohort studies. Most patients suspecting tachyphylaxis are actually experiencing technique drift (different injector, different product, dose changes); switching brands is a reasonable first diagnostic step before assuming true antibody response.

Brands and Korean technique conventions

The brand landscape in Korean clinics is unusually varied — six MFDS-approved domestic brands plus the major international imports. The Korean dermatology community has accumulated decades of experience comparing them in clinical practice.

The Korean injection convention favors lower per-site doses (typically 2–4 units of Botox per injection point on the forehead vs the 4–8 units sometimes used in Western practice) with closer spacing of injection points. The philosophy is to soften muscle activity rather than freeze it; over-dosing produces frozen results that read as obviously treated. Ask which brand the clinic uses by default and whether you can choose.

The per-indication map

Botox addresses many distinct indications. The procedural plan depends on which combination of indications you're addressing in a single session.

Unit ranges vary by brand (different brands have different unit-equivalencies) and by patient muscle bulk. Smaller patients with less developed muscles need less; larger patients or patients with strong-set features need more. The dose recommendation should be customized at consultation rather than applied as a generic protocol.

Cost in Gangnam

Botox pricing in Korean clinics is the most variable of any K-beauty procedure because brand choice, dilution, and indication interact. The numbers below are clinic-quoted ranges as of 2026:

For comparison: equivalent botox treatment in Manhattan typically runs $400–$700 for a full upper face package using Allergan Botox; London £300–£500. The price gap between Gangnam and Western markets is meaningful in percentage terms but the absolute amounts are smaller than for surgical procedures, so the case for traveling specifically for botox alone is narrow. Patients combining botox with other Korea-trip procedures get the per-treatment savings as a side effect rather than the primary trip rationale.

Recovery, day by day

Botox has the shortest recovery of any procedure on this site. Most patients return to normal activity the same day:

Trip duration: same-day procedure; minimum 1-day trip if not combined with other Korea work. Combining with shopping or sightseeing is the typical tourist pattern. Avoid alcohol for 24 hours pre and 48 hours post (alcohol increases bruising). Avoid hot saunas, jjimjilbang, and hot yoga for 24–48 hours post-injection (heat can affect toxin distribution).

The 10 questions to ask in your consultation

Suggested questions for your botox consultation. The brand, dose, and per-indication-mix questions are the highest-impact decisions. Botox consultations are typically shorter than for surgical procedures, so brevity matters.

1. Which brand will you use, and why this brand for my case? Korean clinics often default to whichever domestic brand they have the best supply contract on. Ask whether you can choose Allergan, a different domestic, or a different formulation if you have a reason.
2. What's your dose recommendation per zone, and how does it compare to the international standard? Korean conventions typically run lower than the typical Western dose; if the recommended dose seems high for your muscle bulk, ask how it compares.
3. Will the treatment include glabella + forehead together, or just forehead? Forehead-only treatment without paired glabella can produce brow heaviness; the answer should reference the muscle-balance reasoning.
4. For masseter: how many units per side, and over how many sessions? Masseter slimming typically requires 2–3 sessions over 6–9 months for full effect; first-session dosing varies but is usually conservative.
5. What's your touch-up policy at week 2? Most Korean clinics include a free touch-up if any zone is undertreated; most reputable clinics in Gangnam include this in the original price.
6. What's your protocol if eyelid or brow ptosis develops? Standard is apraclonidine eye drops for ptosis and reassurance for brow heaviness; the surgeon should describe this without hesitation.
7. What's the expected duration for my dose and brand? 3–4 months for cosmetic, 4–6 months for masseter is the typical range; significantly longer or shorter expectations warrant follow-up.
8. Are there pre-injection precautions I should follow? Avoid blood-thinning supplements (fish oil, vitamin E) and alcohol for 5 days pre-injection to reduce bruising risk.
9. What happens if I have a paradoxical or asymmetric result? Touch-up at week 2 corrects most asymmetries; some clinics include this in the original price.
10. What's the all-in price including consultation, brand surcharge, and any touch-ups? Get the all-in number in writing; brand surcharges can vary by 50–100% between Korean domestic and Allergan/Galderma.

Choosing a clinic

Botox is the most-offered cosmetic procedure in Gangnam — virtually every plastic surgery clinic, dermatology clinic, and aesthetic medicine practice provides it. Features commonly associated with experienced botox practices:

• Multiple brands available, including at least one Korean domestic and at least one imported option, with the clinic able to discuss tradeoffs.
• Per-indication unit guidance is consistent with published Korean conventions rather than aggressively higher to drive revenue.
• Free or included touch-up at week 2 as part of the original treatment price.
• Conservative recommendations for first-time patients — clinics that suggest aggressive multi-zone treatment to a novice patient are optimizing for revenue rather than outcome.
• Pre-treatment imaging or photographs for tracking results across sessions, particularly for masseter where bilateral comparison matters.
• Patient-friendly documentation of brand used, units injected per zone, and dilution. Clinics that don't document make it impossible to compare across visits.

The filtered clinic directory shows current matches. The shortlist for botox is the largest of any K-beauty procedure because the volume is distributed across many clinics.

Risks, complications, and what a safe clinic looks like

The published AE rates for cosmetic botox in trained hands sit roughly here: eyelid ptosis 1–3%, brow ptosis 2–5%, asymmetric expression 5–10% (most resolve at week 2 touch-up), pinpoint bruising 10–20% (resolves in 3–7 days), allergic reaction under 0.1%, antibody-mediated resistance 1–3% in long-term users. Masseter-specific: paradoxical bulging during chewing 5–10% in first session (typically resolves), temporary chewing weakness 5–10%.

Recognition. Most botox complications develop over the first 5–14 days as effect onsets. Patient-side signals worth knowing: visible eyelid droop on one side at day 5–10 (likely diffusion-related ptosis), heavy or low-set brow appearance at day 7–14 (likely over-treated frontalis without paired glabella), asymmetric smile or expression at day 7–14 (correctable with week-2 touch-up), inability to fully close eyes (rare but warrants same-week clinic contact).

Reversal. Botox effect cannot be reversed; it must wear off. Eyelid ptosis can be temporarily improved with apraclonidine eye drops (lifts the lid 1–3 mm). Asymmetry can be balanced with strategic additional injection on the under-treated side. Frozen-looking results from over-treatment have to be waited out (typically 2–3 months for the dramatic appearance to fade).

Documentation. Pre-treatment photos from multiple angles, brand and unit count per zone, dilution recorded, post-treatment 1-month and 3-month photos. Clinics that maintain this protocol are tracking outcomes systematically, which matters more for repeat-treatment patients than for one-time visits.

Who is a good candidate (and who is not)

Botox is well-tolerated and has wide candidacy. The ideal candidate is age 18+, in good general health, with dynamic facial lines or muscle-driven appearance concerns (frown, forehead lines, masseter-driven jaw width, etc.) and realistic expectations grounded in a 3–5 month effect window. First-time patients are generally well-served by conservative initial dosing with the option of touch-up at week 2.

Reasons to wait or skip: pregnancy or breastfeeding (no safety data; postponed elective treatment is the standard guidance), active autoimmune conditions affecting neuromuscular transmission (myasthenia gravis, Lambert-Eaton syndrome, ALS — all absolute contraindications), recent course of aminoglycoside antibiotics (gentamicin, tobramycin — interact with neuromuscular signaling; consult your prescribing physician before pausing any medication), known hypersensitivity to botulinum toxin, active infection at the planned injection sites, severe systemic disease, or significant unrealistic expectations.

For older patients (60+): static lines (lines visible at rest, not just with movement) often need filler or skin treatments rather than botox, which addresses dynamic lines. The honest consultation will sometimes suggest combination therapy or alternatives rather than higher-dose botox.

For male patients: dose ranges typically run higher than for female patients due to greater muscle bulk; the unit recommendations cited above are female-typical and may need 1.3–1.5× scaling for men.

When to travel and how long to stay

Botox is the easiest K-beauty procedure to fit into any Korea trip. The minimum stay is the day of the appointment plus enough time for any travel back; many patients combine it with shopping or sightseeing.

Minimum: 1 day. Same-day procedure with no recovery requirement beyond avoiding heavy exercise for 24 hours. Patients flying in from neighboring countries (Japan, China, Vietnam) routinely do day trips.

Optimal for first-time patients: 3 days. Day 1 consult, Day 2 treatment, Day 3 buffer for any minor bruising to fade before flying. Less rushed than a same-day approach.

For week-2 touch-up: Some patients schedule botox at the start of a longer Korea trip and book the touch-up at day 14 before flying home. This is the cleanest version of the treatment but requires a 2-week stay.

Combination trips: botox combines naturally with filler in the same visit — the standard "botox + filler" Korean aesthetic-medicine package. Combined with surgical procedures (rhinoplasty, DES, contouring) is reasonable but should be timed: botox before surgery (so the cosmetic effect is settled by the time you're recovering from surgery) or 4–6 weeks after (so post-surgical swelling doesn't affect placement assessment).

Tax refund, cash discount, and seasonal deals

Three layers of price reduction stack at most clinics. Because botox base prices are lower than other K-beauty categories, the absolute savings are smaller but the percentage applies normally:

VAT refund. Up to 10% of the procedure cost, recoverable at Incheon Airport for foreigners on tourist visas — but only at clinics registered with Korea's Medical Tourist Tax Refund program, and only for procedures coded as eligible cosmetic services. Cosmetic botox almost always qualifies. Functional indications (chronic migraine, hyperhidrosis) sometimes code as medically necessary, which can change refund eligibility — confirm with the clinic. Either Global Tax Free or KT Tourism Tax Refund handles most refunds. The tax refund calculator shows what you'll actually recover after fees.

Cash discount. Typically 3–10%. The lower-end bottoms reflect the lower absolute amounts; for a ₩100,000 forehead session, the cash discount may be ₩5,000.

Seasonal promotions. Botox is the K-beauty procedure with the most aggressive seasonal promotional pricing. Spring and pre-Chuseok windows often see 15–30% discounts on standalone botox, and clinic-published "package" pricing (botox + filler bundles, multi-zone packages) is often discounted year-round. The advertised discounts are real but verify what's included; some packages bundle line items the patient didn't request.

Alternatives to consider instead

Botox is the right answer to dynamic muscle-driven concerns. If your case is something else, consider these alternatives:

• Static lines (lines visible at rest, not just with movement). Filler, skin boosters (Profhilo, Restylane Skinboosters), or skin-resurfacing treatments (lasers, microneedling, chemical peels) address static-line concerns more effectively than botox.
• Bone-driven facial width (square jaw from skeletal anatomy). Mandibular angle reduction addresses bone-driven width that botox cannot reduce. The pre-injection imaging step distinguishes muscle-driven from bone-driven cases.
• Sun damage and skin texture. Energy-based devices (HIFU, RF, fractional lasers), chemical peels, and topical regimens address skin-quality concerns more effectively than botox.
• Subtle volume restoration. Filler, fat grafting, or biostimulators address volume loss that creates aging concerns; botox doesn't add volume.
• Non-treatment. Patients with mild dynamic lines or naturally expressive faces sometimes benefit more from accepting the lines than from softening them. Botox doesn't reverse aging — it changes how dynamic expression looks. Some patients reassess after first treatment and choose not to continue; that's a reasonable outcome.

A serious botox consultation will sometimes recommend a different procedure entirely, suggest waiting, or recommend conservative dosing. That signals an outcome-focused practice rather than a high-volume injection conveyor.

The bottom line

The case for Gangnam for botox specifically is straightforward but narrow. Korean clinics offer broader brand availability than most international markets — six MFDS-approved domestic brands plus the major imports — and the per-treatment pricing is materially lower than in the US, UK, or most of Western Europe. The clinical experience of senior Korean injectors with masseter botox in particular is uncommon globally; the Korean masseter-slimming technique was developed and refined here, and the per-injector volume on this specific indication is high.

The case against is that botox is the K-beauty procedure for which the trip-and-time costs absorb the largest share of the per-treatment savings. Standalone botox in the US runs $400–$700 for a full upper face; in Gangnam the same treatment is $150–$380. The price gap is real but the absolute savings ($250–$320) often don't cover a flight and a few days off work for a patient who has competent local injection options. Botox is the K-beauty procedure most often combined with another Korea-trip procedure as a side benefit rather than the trip's primary rationale.

The patients for whom Gangnam botox is most clearly the right call are those already coming to Korea for surgical procedures (rhinoplasty, DES, contouring) and adding botox to the same trip; patients seeking high-dose specialized indications (trapezius slimming, complex masseter sculpting) where per-injector experience matters; and patients in Asia-Pacific countries where flight costs are low enough that the per-treatment savings dominate the trip math.

For most international patients, the consultation conversation that matters most is the brand-and-dose conversation, not the technique conversation. Korean clinics differ in their default brand and their default per-zone unit count more than they differ in technique; understanding which brand and what dose is being recommended is the highest-leverage part of the consultation. A patient who arrives knowing their preferred brand (or at least having a reasoned preference) and accepting conservative first-time dosing typically has the best outcomes.

If you do come, four practical notes. First, ask explicitly about brand and per-zone unit count rather than accepting a lump-sum price quote. The brand variance is real and the dose variance is larger than most patients realize. Second, plan for a week-2 touch-up in your trip schedule if possible; many clinics include this in the price and it materially affects final symmetry. Third, avoid blood-thinning supplements and alcohol for 5 days pre-treatment — bruising rates are meaningfully higher otherwise. Fourth, treat the first session as exploratory; the right dose for you isn't visible until you've seen one cycle of effect at week 2 and 6 weeks.

Beyond that, Gangnam combines well with botox as a low-friction add-on to other procedures. The injection itself takes 10–15 minutes; recovery is essentially zero; the result is visible by week 2. For most international patients, that's the right framing — botox as a side benefit to a Korea trip rather than the reason for one.